BENDER LEWIS H 4
4 · INTENSITY THERAPEUTICS, INC. · Filed May 6, 2025
Insider Transaction Report
Form 4
BENDER LEWIS H
DirectorPresident and CEO10% Owner
Transactions
- Award
Stock Option (right to buy Common Stock)
2025-05-02+700,000→ 700,000 totalExercise: $0.57Exp: 2035-05-02→ Common Stock (700,000 underlying)
Footnotes (1)
- [F1]This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on May 2, 2025.